Lon White - Related publications

Affiliations: 
University of Hawai'i at Manoa, Honolulu, HI 
Area:
Pathology, Neuroscience Biology
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Volicer L. Physiological and pathological functions of beta-amyloid in the brain and alzheimer's disease: A review. The Chinese Journal of Physiology. 63: 95-100. PMID 32594062 DOI: 10.4103/CJP.CJP_10_20   
2020 Vasanthakumar A, Davis JW, Idler K, Waring JF, Asque E, Riley-Gillis B, Grosskurth S, Srivastava G, Kim S, Nho K, Nudelman KNH, Faber K, Sun Y, Foroud TM, Estrada K, ... , et al. Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease. Clinical Epigenetics. 12: 84. PMID 32539856 DOI: 10.1186/s13148-020-00864-y   
2020 Leblhuber F, Steiner K, Geisler S, Fuchs D, Gostner JM. On the possible relevance of bottom-up pathways in the pathogenesis of Alzheimer's dementia. Current Topics in Medicinal Chemistry. PMID 32407280 DOI: 10.2174/1568026620666200514090359   
2020 Xue M, Sun FR, Ou YN, Shen XN, Li HQ, Huang YY, Dong Q, Tan L, Yu JT, . Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer's disease. Aging. 12. PMID 32421689 DOI: 10.18632/aging.103211   
2020 Sharma A, Weber D, Raupbach J, Dakal TC, Fließbach K, Ramirez A, Grune T, Wüllner U. Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease. Redox Biology. 34: 101546. PMID 32460130 DOI: 10.1016/j.redox.2020.101546   
2020 Rostamzadeh A, Jessen F. [Early detection of Alzheimer's disease and dementia prediction in patients with mild cognitive impairment : Summary of current recommendations]. Der Nervenarzt. PMID 32300816 DOI: 10.1007/s00115-020-00907-y   
2020 Irwin DJ, Felder J, Coffey CS, Caspell-Garcia C, Kang JH, Simuni T, Foroud T, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Weintraub D, Mollenhauer B, ... , et al. Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease. Annals of Neurology. PMID 32542885 DOI: 10.1002/ana.25811   
2020 Bellou E, Baker E, Leonenko G, Bracher-Smith M, Daunt P, Menzies G, Williams J, Escott-Price V, . Age-dependent effect of APOE and polygenic component on Alzheimer's disease. Neurobiology of Aging. 93: 69-77. PMID 32464432 DOI: 10.1016/j.neurobiolaging.2020.04.024   
2020 Akhter F, Chen D, Akhter A, Sosunov AA, Chen A, McKhann GM, Yan SF, Yan SS. High Dietary Advanced Glycation End Products Impair Mitochondrial and Cognitive Function. Journal of Alzheimer's Disease : Jad. PMID 32444539 DOI: 10.3233/JAD-191236   
2020 Jellinger KA. Neuropathological findings in multiple system atrophy with cognitive impairment. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 32367182 DOI: 10.1007/s00702-020-02201-2   
2020 Euesden J, Gowrisankar S, Qu AX, Jean PS, Hughes AR, Pulford DJ. Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting. Genes. 11. PMID 32370229 DOI: 10.3390/genes11050501   
2020 de Heus RAA, de Jong DLK, Rijpma A, Lawlor BA, Olde Rikkert MGM, Claassen JAHR. Orthostatic blood pressure recovery is associated with the rate of cognitive decline and mortality in clinical Alzheimer's disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 32449919 DOI: 10.1093/gerona/glaa129   
2020 de Oliveira FF, Machado FC, Sampaio G, Marin SMC, Naffah-Mazzacoratti MDG, Bertolucci PHF. Neuropsychiatric feature profiles of patients with Lewy body dementia. Clinical Neurology and Neurosurgery. 194: 105832. PMID 32311617 DOI: 10.1016/j.clineuro.2020.105832   
2020 Blair JC, Lasiecka ZM, Patrie J, Barrett MJ, Druzgal TJ. Cytoarchitectonic Mapping of MRI Detects Rapid Changes in Alzheimer's Disease. Frontiers in Neurology. 11: 241. PMID 32425868 DOI: 10.3389/fneur.2020.00241   
2020 Pérez-González M, Mendioroz M, Badesso S, Sucunza D, Roldan M, Espelosín M, Ursua S, Luján R, Cuadrado-Tejedor M, Garcia-Osta A. PLA2G4E, a candidate gene for resilience in Alzheimer´s disease and a new target for dementia treatment. Progress in Neurobiology. 101818. PMID 32380223 DOI: 10.1016/j.pneurobio.2020.101818   
2020 McKiernan EF, Mak E, Dounavi ME, Wells K, Ritchie C, Williams G, Su L, O'Brien J. Regional hyperperfusion in cognitively normal allele carriers in mid-life: analysis of ASL pilot data from the PREVENT-Dementia cohort. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32586852 DOI: 10.1136/jnnp-2020-322924   
2020 Luchsinger JA, Palta P, Rippon B, Sherwood G, Soto L, Ceballos F, Laing K, Igwe K, He H, Razlighi Q, Teresi J, Moreno H, Brickman AM. Pre-Diabetes, but not Type 2 Diabetes, Is Related to Brain Amyloid in Late Middle-Age. Journal of Alzheimer's Disease : Jad. PMID 32390636 DOI: 10.3233/JAD-200232   
2020 Kim JW, Byun MS, Yi D, Lee JH, Jeon SY, Ko K, Jung G, Lee HN, Lee JY, Sohn CH, Lee YS, Shin SA, Kim YK, Lee DY, . Serum Uric Acid, Alzheimer-Related Brain Changes, and Cognitive Impairment. Frontiers in Aging Neuroscience. 12: 160. PMID 32581770 DOI: 10.3389/fnagi.2020.00160   
2020 Sultan S, Taimuri U, Basnan SA, Ai-Orabi WK, Awadallah A, Almowald F, Hazazi A. Low Vitamin D and Its Association with Cognitive Impairment and Dementia. Journal of Aging Research. 2020: 6097820. PMID 32399297 DOI: 10.1155/2020/6097820   
2020 O'Bryant SE, Zhang F, Silverman W, Lee JH, Krinsky-McHale SJ, Pang D, Hall J, Schupf N. Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12033. PMID 32490140 DOI: 10.1002/dad2.12033   
2020 Khandker RK, Ritchie CW, Black CM, Wood R, Jones E, Hu X, Ambegaonkar BM. Multi-National, Cross-Sectional Survey of Healthcare Resource Utilization in Patients with All Stages of Cognitive Impairment, Analyzed by Disease Severity, Country, and Geographical Region. Journal of Alzheimer's Disease : Jad. PMID 32390613 DOI: 10.3233/JAD-190760   
2020 Adams JL, Myers TL, Waddell EM, Spear KL, Schneider RB. Telemedicine: A valuable tool in neurodegenerative diseases. Current Geriatrics Reports. 9: 72-81. PMID 32509504 DOI: 10.1007/s13670-020-00311-z   
2020 Cheng X, Song C, Du Y, Gaur U, Yang M. Pharmacological Treatment of Alzheimer's Disease: Insights from . International Journal of Molecular Sciences. 21. PMID 32610577 DOI: 10.3390/ijms21134621   
2020 Anderson JAE, Hawrylewicz K, Grundy JG. Does bilingualism protect against dementia? A meta-analysis. Psychonomic Bulletin & Review. PMID 32462636 DOI: 10.3758/s13423-020-01736-5   
2020 Thomas AJ, Hamilton CA, Donaghy PC, Martin-Ruiz C, Morris CM, Barnett N, Olsen K, Taylor JP, O'Brien JT. Prospective Longitudinal Evaluation of Cytokines in mild cognitive impairment due to AD and Lewy Body Disease. International Journal of Geriatric Psychiatry. PMID 32557792 DOI: 10.1002/gps.5365   
2020 Rai L, Boyle R, Brosnan L, Rice H, Farina F, Tarnanas I, Whelan R. Digital Biomarkers Based Individualized Prognosis for People at Risk of Dementia: the AltoidaML Multi-site External Validation Study. Advances in Experimental Medicine and Biology. 1194: 157-171. PMID 32468532 DOI: 10.1007/978-3-030-32622-7_14   
2020 Mamun AA, Uddin MS, Bin Bashar MF, Zaman S, Begum Y, Bulbul IJ, Islam MS, Sarwar MS, Mathew B, Amran MS, Md Ashraf G, Bin-Jumah MN, Mousa SA, Abdel-Daim MM. Molecular Insight into the Therapeutic Promise of Targeting for Alzheimer's Disease. Oxidative Medicine and Cellular Longevity. 2020: 5086250. PMID 32509144 DOI: 10.1155/2020/5086250   
2020 Malpetti M, Kievit RA, Passamonti L, Jones PS, Tsvetanov KA, Rittman T, Mak E, Nicastro N, Bevan-Jones WR, Su L, Hong YT, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease. Brain : a Journal of Neurology. PMID 32380523 DOI: 10.1093/brain/awaa088   
2020 Jang JW, Kim Y, Kim S, Park SW, Kwon SO, Park YH, Lim JS, Youn YC, Hun Kim S, Kim S, . Dynamic association between AT(N) profile and cognition mediated by cortical thickness in Alzheimer's continuum. Neuroimage. Clinical. 27: 102282. PMID 32590333 DOI: 10.1016/j.nicl.2020.102282   
2020 Park KS, Ganesh AB, Berry NT, Mobley YP, Karper WB, Labban JD, Wahlheim CN, Williams TM, Wideman L, Etnier JL. The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial. Bmc Neurology. 20: 231. PMID 32503473 DOI: 10.1186/s12883-020-01732-1   
2020 Azar M, Chapman S, Gu Y, Leverenz JB, Stern Y, Cosentino S. Cognitive tests aid in clinical differentiation of Alzheimer's disease versus Alzheimer's disease with Lewy body disease: Evidence from a pathological study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32558217 DOI: 10.1002/alz.12120   
2020 Aschenbrenner AJ, Petros J, McDade E, Wang G, Balota DA, Benzinger TL, Cruchaga C, Goate A, Xiong C, Perrin R, Fagan AM, Graff-Radford N, Ghetti B, Levin J, Weidinger E, ... , et al. Relationships between big-five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12038. PMID 32587883 DOI: 10.1002/dad2.12038   
2020 Rouch I, Padovan C, Boublay N, Pongan E, Laurent B, Trombert-Paviot B, Krolak-Salmon P, Dorey JM. Association between executive function and the evolution of behavioral disorders in Alzheimer's disease. International Journal of Geriatric Psychiatry. PMID 32383491 DOI: 10.1002/gps.5327   
2020 Dicks E, van der Flier WM, Scheltens P, Barkhof F, Tijms BM, . Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's disease. Neurobiology of Aging. 94: 71-80. PMID 32585492 DOI: 10.1016/j.neurobiolaging.2020.05.008   
2020 Park KH, Lim JS, Seo SW, Jeong Y, Noh Y, Koh SH, Bae JS, Park SA, Yang SJ, Kim HJ, Chin J, Roh JH, An SSA, . Executive Summary of the 2019 International Conference of Korean Dementia Association: Exploring the Novel Concept of Alzheimer's Disease and Other Dementia: a Report from the Academic Committee of the Korean Dementia Association. Dementia and Neurocognitive Disorders. 19: 39-53. PMID 32602279 DOI: 10.12779/dnd.2020.19.2.39   
2020 Khedr EM, Ahmed OG, Sayed HM, Abo-Elfetoh N, Ali AM, Gomaa AM. Electrophysiological differences in cortical excitability in different forms of dementia: A transcranial magnetic stimulation and laboratory biomarkers study. Neurophysiologie Clinique = Clinical Neurophysiology. PMID 32591186 DOI: 10.1016/j.neucli.2020.05.001   
2020 Moore EE, Gifford KA, Khan OA, Liu D, Pechman KR, Acosta LMY, Bell SP, Turchan M, Landman BA, Blennow K, Zetterberg H, Hohman TJ, Jefferson AL. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32378327 DOI: 10.1002/alz.12087   
2020 Isik AT, Danyeli AE, Kaya D, Soysal P, Karabay N, Gokden M. The importance of brain banking for dementia practice: the first experience of Turkey. Cell and Tissue Banking. PMID 32435952 DOI: 10.1007/s10561-020-09835-2   
2020 Santangelo R, Masserini F, Agosta F, Sala A, Caminiti SP, Cecchetti G, Caso F, Martinelli V, Pinto P, Passerini G, Perani D, Magnani G, Filippi M. CSF p-tau/Aβ ratio and brain FDG-PET may reliably detect MCI "imminent" converters to AD. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32415550 DOI: 10.1007/s00259-020-04853-4   
2020 Khatri U, Kwon GR. An Efficient Combination among sMRI, CSF, Cognitive Score, and 4 Biomarkers for Classification of AD and MCI Using Extreme Learning Machine. Computational Intelligence and Neuroscience. 2020: 8015156. PMID 32565773 DOI: 10.1155/2020/8015156   
2020 Wang P, Zhou B, Yao H, Xie S, Feng F, Zhang Z, Guo Y, An N, Zhou Y, Zhang X, Liu Y. Aberrant Hippocampal Functional Connectivity Is Associated with Fornix White Matter Integrity in Alzheimer's Disease and Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 32390630 DOI: 10.3233/JAD-200066   
2020 Kolanko M, Win Z, Patel N, Malik O, Carswell C, Gontsarova A, Nicholas R, Perry R, Malhotra P. Using amyloid PET imaging to diagnose Alzheimer's disease in patients with multiple sclerosis. Journal of Neurology. PMID 32556533 DOI: 10.1007/s00415-020-09969-z   
2020 Murakami M, Ikeda Y, Nakagawa Y, Tsuji A, Kitagishi Y, Matsuda S. Special bioactive compounds and functional foods may exhibit neuroprotective effects in patients with dementia (Review). Biomedical Reports. 13: 1. PMID 32509304 DOI: 10.3892/br.2020.1310   
2020 Lam S, Bayraktar A, Zhang C, Turkez H, Nielsen J, Boren J, Shoaie S, Uhlen M, Mardinoglu A. A systems biology approach for studying neurodegenerative diseases. Drug Discovery Today. PMID 32442631 DOI: 10.1016/j.drudis.2020.05.010   
2020 Lyons CE, Bartolomucci A. Stress and Alzheimer's Disease: A Senescence Link? Neuroscience and Biobehavioral Reviews. PMID 32461080 DOI: 10.1016/j.neubiorev.2020.05.010   
2020 Plascencia-Villa G, Perry G. Preventive and therapeutic strategies in Alzheimer's disease: focus on oxidative stress, redox metals and ferroptosis. Antioxidants & Redox Signaling. PMID 32486897 DOI: 10.1089/ars.2020.8134   
2020 Uddin MS, Rahman MA, Kabir MT, Behl T, Mathew B, Perveen A, Barreto GE, Bin-Jumah MN, Abdel-Daim MM, Ashraf GM. Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer's disease. Iubmb Life. PMID 32472959 DOI: 10.1002/iub.2324   
2020 Strickland SL, Reddy JS, Allen M, N'songo A, Burgess JD, Corda MM, Ballard T, Wang X, Carrasquillo MM, Biernacka JM, Jenkins GD, Mukherjee S, Boehme K, Crane P, Kauwe JS, ... , et al. MAPT haplotype-stratified GWAS reveals differential association for AD risk variants. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32400971 DOI: 10.1002/alz.12099   
2020 Sintini I, Graff-Radford J, Senjem ML, Schwarz CG, Machulda MM, Martin PR, Jones DT, Boeve BF, Knopman DS, Kantarci K, Petersen RC, Jack CR, Lowe VJ, Josephs KA, Whitwell JL. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes. Brain : a Journal of Neurology. PMID 32572464 DOI: 10.1093/brain/awaa155   
2020 Reus LM, Stringer S, Posthuma D, Teunissen CE, Scheltens P, Pijnenburg YAL, Visser PJ, Tijms BM, . Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluid. Neurobiology of Aging. PMID 32307133 DOI: 10.1016/j.neurobiolaging.2020.03.012